The Effects of Different Doses of Sildenafil on Coronary Blood Flow and Oxidative Stress in Isolated Rat Hearts

被引:2
作者
Banjac, Nada [1 ]
Vasovic, Velibor [2 ]
Stilinovic, Nebojsa [2 ]
Tomas, Ana [2 ]
Vasovic, Lucija [3 ]
Martic, Nikola [2 ]
Prodanovic, Dusan [2 ]
Jakovljevic, Vladimir [4 ]
机构
[1] Univ Banja Luka, Med Fac, Banja Luka 78000, Bosnia & Herceg
[2] Univ Novi Sad, Fac Med, Dept Pharmacol Toxicol & Clin Pharmacol, Novi Sad 21000, Serbia
[3] Univ Novi Sad, Fac Med, Novi Sad 21000, Serbia
[4] Univ Kragujevac, Fac Med Sci, Dept Physiol, Kragujevac 34000, Serbia
关键词
sildenafil; phosphodiesterase; isolated rat heart; oxidative stress; coronary flow; OXIDE SYNTHASE INHIBITION; NITRIC-OXIDE; CARDIAC CONTRACTILITY; PULMONARY VEIN; INFARCT SIZE; CARDIOPROTECTION; TADALAFIL; FAILURE; PATHWAY; DISEASE;
D O I
10.3390/ph16010118
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The dose-response relationship of sildenafil effects on cardiac function is not completely elucidated. The aim of this study was to assess the effects of different doses of sildenafil on coronary flow and oxidative stress in isolated rat hearts. Coronary flow and markers of oxidative stress, including nitrite outflow, and superoxide anion production in coronary effluent, were determined for isolated rat hearts. The experiments were performed during control conditions and in the presence of sildenafil (10, 20, 50, 200 nM) alone or with N omega-nitro-L-arginine monomethyl ester (L-NAME) (30 mu M). Sildenafil was shown to result in a significant increase in coronary flow at lower coronary perfusion pressure (CPP) values at all administered doses, whereas, with an increase in CPP, a reduction in coronary flow was observed. An increase in nitric oxide (NO) was most pronounced in the group treated with the lowest dose of sildenafil at the highest CPP value. After the inhibition of the NO-cyclic guanosine monophosphate (cGMP) signaling (NOS) system by L-NAME, only a dose of 200 nM sildenafil was high enough to overcome the inhibition and to boost release of O-2(-). That effect was CPP-dependent, with statistical significance reached at 80, 100 and 120 mmHg. Our findings indicate that sildenafil causes changes in heart vasculature in a dose-dependent manner, with a shift from a vasodilatation effect to vasoconstriction with a pressure increase. The highest dose administered is capable of producing superoxide anion radicals in terms of NOS system inhibition.
引用
收藏
页数:13
相关论文
共 47 条
[11]   Effect of sildenafil on reperfusion function, infarct size, and cyclic nucleotide levels in the isolated rat heart model [J].
du Toit, EF ;
Rossouw, E ;
Salie, R ;
Opie, LH ;
Lochner, A .
CARDIOVASCULAR DRUGS AND THERAPY, 2005, 19 (01) :23-31
[12]   Arginase: A critical regulator of nitric oxide synthesis and vascular function [J].
Durante, William ;
Johnson, Fruzsina K. ;
Johnson, Robert A. .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2007, 34 (09) :906-911
[13]   Sildenafil-mediated acute cardioprotection is independent of the NO/cGMP pathway [J].
Elrod, John W. ;
Greer, James J. M. ;
Lefer, David J. .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2007, 292 (01) :H342-H347
[14]   Sildenafil reduces cardiovascular remodeling associated with hypertensive cardiomyopathy in NOS inhibitor-treated rats [J].
Ferreira-Melo, Silvia Elaine ;
Yugar-Toledo, Juan Carlos ;
Coelho, Otavio Rizzi ;
De Luca, Iara M. ;
Tanus-Santos, Jose Eduardo ;
Hyslop, Stephen ;
Irigoyen, Mania Claudia ;
Moreno, Heitor, Jr. .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2006, 542 (1-3) :141-147
[15]  
Gresser U, 2002, EUR J MED RES, V7, P435
[16]   Sildenafil ameliorates left ventricular T-tubule remodeling in a pressure overload-induced murine heart failure model [J].
Huang, Chun-kai ;
Chen, Bi-yi ;
Guo, Ang ;
Chen, Rong ;
Zhu, Yan-qi ;
Kutschke, William ;
Hong, Jiang ;
Song, Long-sheng .
ACTA PHARMACOLOGICA SINICA, 2016, 37 (04) :473-482
[17]   Phosphodiesterase-5 inhibitors and the heart: compound cardioprotection? [J].
Hutchings, David Charles ;
Anderson, Simon George ;
Caldwell, Jessica L. ;
Trafford, Andrew W. .
HEART, 2018, 104 (15) :1244-1250
[18]   The cGMP/PKG pathway as a common mediator of cardioprotection: translatability and mechanism [J].
Inserte, Javier ;
Garcia-Dorado, David .
BRITISH JOURNAL OF PHARMACOLOGY, 2015, 172 (08) :1996-2009
[19]  
Jakovljevic V. Lj, 2006, ACTA PHYSIOLOGICA HUNGARICA, V93, P251, DOI 10.1556/APhysiol.93.2006.4.1
[20]   Influence of acute renal failure on coronary vasoregulation in dogs [J].
Kingma, John G., Jr. ;
Vincent, Chantal ;
Rouleau, Jacques R. ;
Kingma, Iris .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 17 (05) :1316-1324